Ireland
--:--IST
Latest
Clinical Trials in France / NCT07469020
Recruiting Not applicable

CLE-PAD : Prevalence of PAD in Patients With Surgically Lumbar Spinal Stenosis

NCT07469020 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-08
Last updated
2026-08-12

Condition(s) studied

PAD - Peripheral Arterial DiseaseLumbar Spinal StenosisLower Limb Arterial Disease

Investigational drug(s) / intervention(s)

contrast-enhanced CT scan

contrast-enhanced CT scan: contrast-enhanced CT scan

Study summary

The goal of this interventional study is to evaluate the rate of existing lower limb peripheral artery disease (PAD) in patients with surgically lumbar spinal stenosis (LSS). PAD and LSS can present similar symptoms and it can be difficult to diagnose PAD using conventional methods, depending on the location of the arterial disease. The main questions it aims to answer are :

* What's the prevalence of PAD in LSS patients?
* Which exam among routine tools is the most accurate to diagnose PAD in this population? Around their surgery for LSS (a few weeks before or after), participants will be included in a vascular medicine service. After checking of eligibility criteria, they will undergo a contrast-enhanced CT scan for the diagnosis of PAD and various routine diagnostic tests: Doppler ultrasound, treadmill tests, pressure index, pulse palpation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Presenting with a lumbar spinal stenosis with surgical indication, either unoperated or operated on less than 3 months ago * Affiliated with a social security scheme * Having received oral and written information about the protocol and having signed a written consent form to participate in this research. Exclusion Criteria: * emergency surgical care * Contraindication to contrast enhanced CT scan * Stroke or myocardial infarction (MI) within the last 3 months * Known severe or poorly tolerated arrhythmia * Known severe or symptomatic left ventricular outflow obstruction * Decompensated heart failure * History within the last 3 months of venous thromboembolic disease, myopericarditis, endocarditis, aortic dissection or intracardiac thrombus * Severe uncontrolled hypertension (BP \> 200/110 mmHg) * Inability to walk on the treadmill * Major lower limb amputation * Adult subject to legal protection

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Groupement des Hôpitaux de l'Institut Catholique de Lille Lille France Not Yet Recruiting
Groupe hospitalier Paris Saint Joseph Paris France Not Yet Recruiting
CHU Rennes Rennes France Recruiting

More Rennes University Hospital trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07469020 on ClinicalTrials.gov ↗ ← All trials in France